Skip to content
PeptideAgent

Are peptides legal in New Mexico?

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The short answer

Yes. A New Mexico resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a New Mexico-licensed prescriber, including by telehealth, which the New Mexico Telehealth Act (NMSA 1978, sections 24-25-1 to 24-25-7) defines to include interactive audio and video and store-and-forward technology. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the New Mexico Board of Pharmacy; out-of-state pharmacies need a New Mexico nonresident pharmacy license, and nonresident pharmacies that ship sterile compounded preparations such as injectable peptides apply under a separate nonresident sterile application tied to the Board's sterile compounding rule, 16.19.36 NMAC.

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Sep 22, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a New Mexico resident get peptides by telehealth?

The New Mexico Telehealth Act defines telehealth as the use of electronic information, imaging, and communication technologies, including interactive audio, video, and data communications as well as store-and-forward technologies, to deliver and support health care. The Act does not expand any provider's scope of practice or authorize care in a manner not otherwise allowed by law, so prescribing standards come from each licensing board; the prescriber must hold a New Mexico license. Because the Act recognizes store-and-forward delivery but defers to board rules for prescribing, this record leaves questionnaire-only asynchronous prescribing unconfirmed. None of the peptides in this database are controlled substances. [4] [5]

How does the New Mexico pharmacy board treat compounding?

Compounding regulator for New Mexico
BoardNew Mexico Board of Pharmacy (Regulation and Licensing Department)
Eligible substancesFollows the federal 503A framework

The New Mexico Board of Pharmacy regulates pharmacy under the Pharmacy Act (NMSA 1978, sections 61-11-1 and following) and Title 16, Chapter 19 of the New Mexico Administrative Code. 16.19.36 NMAC governs compounded sterile preparations: it requires facilities, environmental monitoring, and written procedures consistent with USP chapter 797, sets minimum dedicated compounding space, and requires training of everyone who performs or oversees sterile compounding. The Board inspects sterile compounders by risk category and uses a separate nonresident sterile pharmacy application for out-of-state pharmacies that ship sterile preparations into New Mexico. Under the Pharmacy Act, NMSA 1978 section 61-11-2 defines a nonresident pharmacy as any pharmacy located outside New Mexico that ships, mails, or delivers drugs into New Mexico, and section 61-11-14 requires anyone who engages in an activity in the state requiring Board licensure to obtain the proper license, listing nonresident pharmacy as a license class. New Mexico has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [2] [3] [6] [7] [9]

Can you get compounded GLP-1s in New Mexico?

Regulatory: Compounded GLP-1 limited

Because compounded GLP-1 injections are sterile preparations, an out-of-state pharmacy shipping them into New Mexico must hold the Board's nonresident sterile licensure and meet 16.19.36 NMAC standards. [6] [7] [12]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in New Mexico?

Verified access options

Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.

Find a provider in New Mexico

Is it legal to buy research peptides in New Mexico?

The New Mexico Drug, Device and Cosmetic Act (NMSA 1978, sections 26-1-1 and following) prohibits selling adulterated or misbranded drugs and limits dispensing of dangerous drugs to licensed practitioners and pharmacies. [8] [13]

Peptide-specific notes for New Mexico

Peptide-specific notes for New Mexico
PeptideNote
TirzepatideAvailable branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and any compounded injection must be prepared under 16.19.36 NMAC or an equivalent nonresident sterile license. [6] [12]

Frequently asked questions

Can I get a GLP-1 prescription in New Mexico through telehealth?

Yes, from a New Mexico-licensed prescriber. The New Mexico Telehealth Act recognizes audio, video, and store-and-forward telehealth, and semaglutide and tirzepatide are not controlled substances. The prescriber's licensing board sets the prescribing standard. [4] [5]

Does the New Mexico Telehealth Act let out-of-state providers treat me without a New Mexico license?

No. The Act states that it does not alter any provider's scope of practice or authorize care in a way not otherwise allowed by law, so the provider still needs New Mexico licensure. [4]

Can an out-of-state pharmacy ship compounded injectable peptides to me in New Mexico?

Only if it holds New Mexico nonresident licensure, and for sterile preparations such as injectable peptides the Board uses a separate nonresident sterile application. Check the Board's license lookup before ordering. [1] [3] [7]

Can a New Mexico pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [9] [10] [11]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.

  1. [1]New Mexico Board of Pharmacy (Regulation and Licensing Department)
  2. [2]NMSA 1978, section 61-11-2, Pharmacy Act definitions (nonresident pharmacy)
  3. [3]NMSA 1978, section 61-11-14, Pharmacy licensure; classes of licenses; requirements; fees; revocation
  4. [4]New Mexico Telehealth Act, NMSA 1978, Chapter 24, Article 25
  5. [5]NMSA 1978, section 24-25-3, Telehealth Act definitions
  6. [6]16.19.36 NMAC, Compounded sterile preparations
  7. [7]New Mexico Board of Pharmacy: nonresident sterile pharmacy application (2022)
  8. [8]New Mexico Drug, Device and Cosmetic Act, NMSA 1978, Chapter 26, Article 1
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, September 22). Are peptides legal in New Mexico?. https://peptideagent.ai/legal/new-mexico
HTML link
<a href="https://peptideagent.ai/legal/new-mexico">Are peptides legal in New Mexico?</a>, PeptideAgent, updated September 22, 2026.